title: [Gout, revisited].
abstract: In recent decades, gout became the most common inflammatory arthritis and one in which pathogenesis and risk factors are best understood. One of the treatment objectives in current guidelines is "cure". However, audits show that minority of patients with gout receive adequate advice and treatment. Doctors often focus on managing acute attacks rather than viewing gout as a chronic progressive crystal deposition disease. Accordingly, urate-lowering treatment is underprescribed and often underdosed. The recent introduction of a panel of new treatments of gout and a better understanding of epidemiologic factors (such as the fructose) may improve management of this easily diagnosed and curable form of potentially severe arthritis, worsening probably the cardiovascular prognostic.
authors: J
authors: J
authors: Bentin
authors: M J
authors: MJ
authors: Fernandez-Lopez
authors: E
authors: E
authors: Dragan
authors: P
authors: P
authors: Eloundou
authors: A
authors: A
authors: Peretz
mesh_terms: D004032:Diet; D019468:Disease Management; D006073:Gout / Q000628:therapy*; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans
chemical_list: D006074:Gout Suppressants